Contact For Attorneys
Settlement Settlement

Acme Pharmaceuticals Drug Recall Settlement

You may be eligible if you purchased or were prescribed Acme blood pressure medication between January 2018 and December 2023 and retained proof of purchase or a pharmacy record.

Check Your Eligibility
$125M
Settlement Fund
May 29, 2026
Deadline
Overview

About This Case

Acme Pharmaceuticals has agreed to a $125 million settlement covering consumers who purchased or were prescribed Acme-brand blood pressure medication between 2018 and 2023. Laboratory testing revealed certain lots contained a potentially carcinogenic impurity at levels exceeding FDA limits.
Get Started

Check Your Eligibility

Complete the form below to determine if you may be eligible to participate in this class action. Your information is kept confidential and submitting this form does not obligate you in any way.

By submitting this form, you consent to being contacted by our partner attorneys regarding this case. Submission does not guarantee eligibility or create an attorney-client relationship. Your information is protected under our Privacy Policy.